SCHEMBL15782891

SCHEMBL15782891

Cc1ccc2c(ccn2CCC(C)(C)O)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.51
HTR2C P28335 2/20 0.51
CDK4 P11802 4/20 0.48
CCND1 P24385 4/20 0.48
MAPT P10636 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
PRMT5 O14744 1/20 0.41
PLG P00747 1/20 0.40
PLAU P00749 1/20 0.40
HTR7 P34969 1/20 0.38
FABP4 P15090 2/20 0.38
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15770690 0.84 CYP19A1 (0.41) HTR2AHTR2CCDK4CCND1PRMT5
SCHEMBL25687334 0.84 HTR2A (0.54) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL18648124 0.82 HTR7 (0.40) CDK4CCND1MAPTPLGPLAU
SCHEMBL11622820 0.80 HTR2A (0.57) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL2035199 0.79 CDK4 (0.63) HTR2AHTR2CCDK4CCND1MTNR1A
SCHEMBL17676473 0.78 HTR2A (0.58) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL10165540 0.78 HTR2A (0.48) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL17676466 0.77 HTR2C (0.57) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL13444442 0.76 HTR2C (0.64) HTR2AHTR2CCDK4CCND1MAPT
SCHEMBL18856946 0.76 HTR2A (0.55) HTR2AHTR2CCDK4CCND1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9597310-B2 Indanyloxydihydrobenzofuranylacetic acids BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-03-21 US disclosed
US-9597310-B2 Indanyloxydihydrobenzofuranylacetic acids BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-03-21 US disclosed
US-20160235706-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-08-18 US disclosed
US-20140163025-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163025-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS GPR119, GPBAR1, GPR52 HTR2A 84/4885HTR2C 270/4885CDK4 2773/4885
US-20160235706-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS GPR119, GPBAR1, GPR52 HTR2A 84/4885HTR2C 270/4885CDK4 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.